Vitreous biomarkers in diabetic retinopathy

A systematic review and meta-analysis

Annie K. McAuley, Paul G. Sanfilippo, Alex W. Hewitt, Helena Liang, Ecosse Lamoureux, Jie Jin Wang, Paul P. Connell

Research output: Contribution to journalArticleResearchpeer-review

24 Citations (Scopus)

Abstract

The aim of this study was to perform a systematic meta-analysis of biomarkers investigated with diabetic retinopathy (DR) in the vitreous, and to explore the molecular pathway interactions of these markers found to be consistently associated with DR. Relevant databases [PubMed and ISI web of science] were searched for all published articles investigating molecular biomarkers of the vitreous associated with DR. Based on set exclusion/inclusion criteria available data from studies with human vitreous samples were extracted and used for our meta-analysis. The interactions of significant biomarkers in DR were investigated via STRING and KEGG pathway analysis. Our meta-analysis of DR identifies eleven biomarkers as potential therapeutic candidates alternate to current anti-VEGF therapy. Four of these are deemed viable therapeutic targets for PDR; ET receptors (ET A and ET B), anti-PDGF-BB, blocking TGF-β using cell therapy and PEDF. The identification of supplementary or synergistic therapeutic candidates to anti VEGF in the treatment of DR may aid in the development of future treatment trials.
Original languageEnglish
Pages (from-to)419-425
Number of pages7
JournalJournal of Diabetes and its Complications
Volume28
Issue number3
DOIs
Publication statusPublished - May 2014
Externally publishedYes

Keywords

  • EPO
  • HGF
  • IL-6
  • IL-8
  • KEGG pathway
  • Macular edema
  • Proliferative retinopathy
  • VEGF
  • Vitrectomy

Cite this

McAuley, A. K., Sanfilippo, P. G., Hewitt, A. W., Liang, H., Lamoureux, E., Wang, J. J., & Connell, P. P. (2014). Vitreous biomarkers in diabetic retinopathy: A systematic review and meta-analysis. Journal of Diabetes and its Complications, 28(3), 419-425. https://doi.org/10.1016/j.jdiacomp.2013.09.010
McAuley, Annie K. ; Sanfilippo, Paul G. ; Hewitt, Alex W. ; Liang, Helena ; Lamoureux, Ecosse ; Wang, Jie Jin ; Connell, Paul P. / Vitreous biomarkers in diabetic retinopathy : A systematic review and meta-analysis. In: Journal of Diabetes and its Complications. 2014 ; Vol. 28, No. 3. pp. 419-425.
@article{646acd9f20324ce4b099e3af18205647,
title = "Vitreous biomarkers in diabetic retinopathy: A systematic review and meta-analysis",
abstract = "The aim of this study was to perform a systematic meta-analysis of biomarkers investigated with diabetic retinopathy (DR) in the vitreous, and to explore the molecular pathway interactions of these markers found to be consistently associated with DR. Relevant databases [PubMed and ISI web of science] were searched for all published articles investigating molecular biomarkers of the vitreous associated with DR. Based on set exclusion/inclusion criteria available data from studies with human vitreous samples were extracted and used for our meta-analysis. The interactions of significant biomarkers in DR were investigated via STRING and KEGG pathway analysis. Our meta-analysis of DR identifies eleven biomarkers as potential therapeutic candidates alternate to current anti-VEGF therapy. Four of these are deemed viable therapeutic targets for PDR; ET receptors (ET A and ET B), anti-PDGF-BB, blocking TGF-β using cell therapy and PEDF. The identification of supplementary or synergistic therapeutic candidates to anti VEGF in the treatment of DR may aid in the development of future treatment trials.",
keywords = "EPO, HGF, IL-6, IL-8, KEGG pathway, Macular edema, Proliferative retinopathy, VEGF, Vitrectomy",
author = "McAuley, {Annie K.} and Sanfilippo, {Paul G.} and Hewitt, {Alex W.} and Helena Liang and Ecosse Lamoureux and Wang, {Jie Jin} and Connell, {Paul P.}",
year = "2014",
month = "5",
doi = "10.1016/j.jdiacomp.2013.09.010",
language = "English",
volume = "28",
pages = "419--425",
journal = "Journal of Diabetes and its Complications",
issn = "1056-8727",
publisher = "Elsevier",
number = "3",

}

McAuley, AK, Sanfilippo, PG, Hewitt, AW, Liang, H, Lamoureux, E, Wang, JJ & Connell, PP 2014, 'Vitreous biomarkers in diabetic retinopathy: A systematic review and meta-analysis', Journal of Diabetes and its Complications, vol. 28, no. 3, pp. 419-425. https://doi.org/10.1016/j.jdiacomp.2013.09.010

Vitreous biomarkers in diabetic retinopathy : A systematic review and meta-analysis. / McAuley, Annie K.; Sanfilippo, Paul G.; Hewitt, Alex W.; Liang, Helena; Lamoureux, Ecosse; Wang, Jie Jin; Connell, Paul P.

In: Journal of Diabetes and its Complications, Vol. 28, No. 3, 05.2014, p. 419-425.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Vitreous biomarkers in diabetic retinopathy

T2 - A systematic review and meta-analysis

AU - McAuley, Annie K.

AU - Sanfilippo, Paul G.

AU - Hewitt, Alex W.

AU - Liang, Helena

AU - Lamoureux, Ecosse

AU - Wang, Jie Jin

AU - Connell, Paul P.

PY - 2014/5

Y1 - 2014/5

N2 - The aim of this study was to perform a systematic meta-analysis of biomarkers investigated with diabetic retinopathy (DR) in the vitreous, and to explore the molecular pathway interactions of these markers found to be consistently associated with DR. Relevant databases [PubMed and ISI web of science] were searched for all published articles investigating molecular biomarkers of the vitreous associated with DR. Based on set exclusion/inclusion criteria available data from studies with human vitreous samples were extracted and used for our meta-analysis. The interactions of significant biomarkers in DR were investigated via STRING and KEGG pathway analysis. Our meta-analysis of DR identifies eleven biomarkers as potential therapeutic candidates alternate to current anti-VEGF therapy. Four of these are deemed viable therapeutic targets for PDR; ET receptors (ET A and ET B), anti-PDGF-BB, blocking TGF-β using cell therapy and PEDF. The identification of supplementary or synergistic therapeutic candidates to anti VEGF in the treatment of DR may aid in the development of future treatment trials.

AB - The aim of this study was to perform a systematic meta-analysis of biomarkers investigated with diabetic retinopathy (DR) in the vitreous, and to explore the molecular pathway interactions of these markers found to be consistently associated with DR. Relevant databases [PubMed and ISI web of science] were searched for all published articles investigating molecular biomarkers of the vitreous associated with DR. Based on set exclusion/inclusion criteria available data from studies with human vitreous samples were extracted and used for our meta-analysis. The interactions of significant biomarkers in DR were investigated via STRING and KEGG pathway analysis. Our meta-analysis of DR identifies eleven biomarkers as potential therapeutic candidates alternate to current anti-VEGF therapy. Four of these are deemed viable therapeutic targets for PDR; ET receptors (ET A and ET B), anti-PDGF-BB, blocking TGF-β using cell therapy and PEDF. The identification of supplementary or synergistic therapeutic candidates to anti VEGF in the treatment of DR may aid in the development of future treatment trials.

KW - EPO

KW - HGF

KW - IL-6

KW - IL-8

KW - KEGG pathway

KW - Macular edema

KW - Proliferative retinopathy

KW - VEGF

KW - Vitrectomy

UR - http://www.scopus.com/inward/record.url?scp=84899411337&partnerID=8YFLogxK

U2 - 10.1016/j.jdiacomp.2013.09.010

DO - 10.1016/j.jdiacomp.2013.09.010

M3 - Article

VL - 28

SP - 419

EP - 425

JO - Journal of Diabetes and its Complications

JF - Journal of Diabetes and its Complications

SN - 1056-8727

IS - 3

ER -